Analystreport

Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at B. Riley. They set a "buy" rating and a $5.00 price target on the stock.

Aptose Biosciences, Inc. - Common Shares  (APTO) 
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: aptose.com/investors